PT  - JOURNAL ARTICLE
AU  - Schirle, Lori
AU  - Jeffery, Alvin
AU  - Yaqoob, Ali
AU  - Sanchez-Roige, Sandra
AU  - Samuels, David
TI  - Two Data-Driven Approaches to Identifying the Spectrum of Problematic Opioid Use: A Pilot Study within a Chronic Pain Cohort
AID  - 10.1101/2021.09.07.21263079
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.07.21263079
4099  - http://medrxiv.org/content/early/2021/09/12/2021.09.07.21263079.short
4100  - http://medrxiv.org/content/early/2021/09/12/2021.09.07.21263079.full
AB  - Background Although electronic health records (EHR) have significant potential for the study of opioid use disorders (OUD), detecting OUD in clinical data is challenging. Models using EHR data to predict OUD often rely on case/control classifications focused on extreme opioid use. There is a need to expand this work to characterize the spectrum of problematic opioid use.Methods Using a large academic medical center database, we developed 2 datadriven methods of OUD detection: (1) a Comorbidity Score developed from a Phenome-Wide Association Study of phenotypes associated with OUD and (2) a Textbased Score using natural language processing to identify OUD-related concepts in clinical notes. We evaluated the performance of both scores against a manual review with correlation coefficients, Wilcoxon rank sum tests, and area-under the receiver operating characteristic curves. Records with the highest Comorbidity and Text-based scores were re-evaluated by manual review to explore discrepancies.Results Both the Comorbidity and Text-based OUD risk scores were significantly elevated in the patients judged as High Evidence for OUD in the manual review compared to those with No Evidence (p = 1.3E-5 and 1.3E-6, respectively). The risk scores were positively correlated with each other (rho = 0.52, p < 0.001). AUCs for the Comorbidity and Text-based scores were high (0.79 and 0.76, respectively). Follow-up manual review of discrepant findings revealed strengths of data-driven methods over manual review, and opportunities for improvement in risk assessment.Conclusion Risk scores comprising comorbidities and text offer differing but synergistic insights into characterizing problematic opioid use. This pilot project establishes a foundation for more robust work in the future.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJeffery, Alvin: Dr. Jeffery received support for this work from the Agency for Healthcare Research and Quality (AHRQ) and the Patient-Centered Outcomes Research Institute (PCORI) under Award Number K12 HS026395. The content is solely the responsibility of the authors and does not necessarily represent the official views of AHRQ, PCORI, or the United States Government. The data used for this publication was supported by CTSA award No. UL1 TR002243 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. Computing for this publication was completed at Translational Sciences and the Advanced Computing Center for Research and Education (ACCRE) High-Memory Compute Nodes under Grant No. 1S10OD023680-01 from the National Institutes of Health. Dr. Sanchez-Roige was supported by funds from the California Tobacco-Related Disease Research Program (TRDRP; Grant Number T29KT0526). Obtained funding: No unique funding was obtained for this project and no funder input into study design, data acquisition, analysis, or interpretation, or manuscript preparation. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was deemed exempt by Vanderbilt University IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon request